AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in core therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology, Infection and Vaccines; and Neuroscience
Driven by innovative science and our entrepreneurial culture, we are focused on the delivery of life-changing medicines that are fuelling growth and contributing value to patients and society.
We recognize that patients are people first and should be at the center of everything we do in specific and measurable ways, from discovery science through clinical trials to prevention, awareness, diagnosis, treatment, and post-treatment.
We are working with partners to help create integrated ‘healthcare ecosystems’ that bring benefits and support for the whole of the patient experience.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Please visit www.astrazeneca.com and follow the Company on Twitter @AstraZeneca